| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Apr―29 |
Effects of resveratrol on inflammatory cytokines in COVID-19 patients: a randomized, double-blinded, placebo-controlled clinical trial |
Alireza Bastin, Thomas Netticadan, Fatemeh Abbasi, Naseeb Rahimi, Marzieh Mahmoodi, Mehdi Alizadeh, Ali Movahed, Mohammad Amin Momeni-Moghaddam |
| 2 |
[GO] |
2024―Nov―09 |
Toll-like receptors polymorphisms and COVID-19: a systematic review |
Barbara Rayssa Correia dos Santos, Luana Karen Correia dos Santos, Jean Moises Ferreira, Ana Caroline Melo dos Santos, Vinicius Albuquerque Sortica, Elaine Virginia Martins de Souza Figueiredo |
| 3 |
[GO] |
2024―Mar―19 |
Investigation of homocysteine, D-dimer and platelet count levels as potential predictors of thrombosis risk in COVID-19 patients |
Zahra Eslamifar, Mahin Behzadifard, Ehsan Zare |
| 4 |
[GO] |
2023―Sep―24 |
A brief overview of SARS-CoV-2 infection and its management strategies: a recent update |
Alakesh Das, Surajit Pathak, Madhavi Premkumar, Chitra Veena Sarpparajan, Esther Raichel Balaji, Asim K. Duttaroy, Antara Banerjee |
| 5 |
[GO] |
2023―May―15 |
Saliva-based detection of SARS-CoV-2: a bibliometric analysis of global research |
Chun Zhou, Zhaopin Cai, Boxing Jin, Huisong Lin, Lingling Xu, Zhigang Jin |
| 6 |
[GO] |
2023―May―02 |
Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspective |
Sukesh Kumar Bajire, Rajesh P. Shastry |
| 7 |
[GO] |
2023―Mar―04 |
Transforming growth factor beta 1 (TGF-β1) in COVID-19 patients: relation to platelets and association with the disease outcome |
Snezana Zivancevic-Simonovic, Rajna Minic, Vojislav Cupurdija, Marijana Stanojevic-Pirkovic, Olivera Milosevic-Djordjevic, Vladimir Jakovljevic, Olgica Mihaljevic |
| 8 |
[GO] |
2023―Mar―03 |
Live to die another day: novel insights may explain the pathophysiology behind smoker’s paradox in SARS-CoV-2 infection |
K. I. Papadopoulos, A. Papadopoulou, T. C. Aw |
| 9 |
[GO] |
2023―Jan―23 |
Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate |
Divya Sharma, Mit Joshi, Subbu Apparsundaram, Ramesh K. Goyal, Bhoomika Patel, Mahaveer Dhobi |
| 10 |
[GO] |
2023―Jan―18 |
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon |
Hayder M. Al-kuraishy, Gaber El-Saber Batiha, Ali I. Al-Gareeb, Nasser A. Hadi Al-Harcan, Nermeen N. Welson |
| 11 |
[GO] |
2022―Nov―22 |
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise |
Omid Razi, Ana Maria Teixeira, Bakhtyar Tartibian, Nastaran Zamani, Beat Knechtle |
| 12 |
[GO] |
2022―Nov―17 |
Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19 |
Dhanashree Murugan, Loganathan Rangasamy |
| 13 |
[GO] |
2022―Oct―29 |
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight |
Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak, Rudranil De |
| 14 |
[GO] |
2022―Oct―27 |
Stability and expression of SARS-CoV-2 spike-protein mutations |
Kristoffer T. Bæk, Rukmankesh Mehra, Kasper P. Kepp |
| 15 |
[GO] |
2022―Aug―29 |
Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19? |
Rakesh C. Kukreja, Rui Wang, Saisudha Koka, Anindita Das, Arun Samidurai, Lei Xi |
| 16 |
[GO] |
2022―Jun―25 |
Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study |
Rashmi Rana, Vivek Ranjan, Naveen Kumar, Parul Chugh, Kamini Khillan, Atul Gogia, Devinder Singh Rana, Nirmal Kumar Ganguly |
| 17 |
[GO] |
2022―Jun―22 |
Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers |
Mahavir Singh, Sathnur Pushpakumar, Nia Bard, Yuting Zheng, Rubens P. Homme, Sri Prakash L. Mokshagundam, Suresh C. Tyagi |
| 18 |
[GO] |
2022―Mar―08 |
Influence of exercise and vitamin D on the immune system against Covid-19: an integrative review of current literature |
Matheus Ribeiro Bizuti, Édina Starck, Kimberly Kamila da Silva Fagundes, Josiano Guilherme Puhle, Lucas Medeiros Lima, Natan Rodrigues de Oliveira, Guilherme Vinicio de Sousa Silva, Débora Tavares Resende e Silva |
| 19 |
[GO] |
2022―Mar―02 |
An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients |
Abhay Srivastava, Cheryl Rockman-Greenberg, Niketa Sareen, Vincenzo Lionetti, Sanjiv Dhingra |
| 20 |
[GO] |
2022―Feb―24 |
Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance |
Farah Anjum, Taj Mohammad, Purva Asrani, Alaa Shafie, Shailza Singh, Dharmendra Kumar Yadav, Vladimir N. Uversky, Md Imtaiyaz Hassan |
| 21 |
[GO] |
2022―Feb―11 |
The crucial role of prolactin-lactogenic hormone in Covid-19 |
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Monica Butnariu, Gaber El-Saber Batiha |
| 22 |
[GO] |
2022―Jan―27 |
Mechanisms contributing to adverse outcomes of COVID-19 in obesity |
Manu Sudhakar, Sofi Beaula Winfred, Gowri Meiyazhagan, Deepa Parvathy Venkatachalam |
| 23 |
[GO] |
2022―Jan―23 |
Ocular transmissibility of COVID-19: possibilities and perspectives |
Gavin Davis, Kin Li, Finosh G. Thankam, Daniel R. Wilson, Devendra K. Agrawal |
| 24 |
[GO] |
2022―Jan―20 |
Re: “Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation” |
Alejandro Marcel Hasslocher-Moreno |
| 25 |
[GO] |
2022―Jan―11 |
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features |
Foad Rommasi, Mohammad Javad Nasiri, Mehdi Mirsaeidi |
| 26 |
[GO] |
2021―Dec―09 |
Correction to: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
Mohammed Tarique, Shaban Ahmad, Arshi Malik, Irfan Ahmad, Mohd Saeed, Ahmad Almatroudi, Talal Qadah, Manal Abdulaziz Murad, Mutaib Mashraqi, Qamre Alam, Yousef Al-Saleh |
| 27 |
[GO] |
2021―Aug―28 |
Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19? |
Sneha Verma, Ved Chaturvedi, N. K. Ganguly, Shivani Arora Mittal |
| 28 |
[GO] |
2021―Jul―28 |
The potential role of neopterin in Covid-19: a new perspective |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Khalid J. Alzahrani, Natália Cruz-Martins, Gaber El-Saber Batiha |
| 29 |
[GO] |
2021―Jun―30 |
A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis |
Sweta Singh, Rakesh Pandey, Sarika Tomar, Raunak Varshney, Darshika Sharma, Gurudutta Gangenahalli |
| 30 |
[GO] |
2021―Jun―24 |
Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment |
Udeep Chawla, Manoj Kumar Kashyap, Amjad Husain |
| 31 |
[GO] |
2021―Jun―10 |
Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation |
Laura Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Dulce Papy-García, Denis Barritault, Edgar Zenteno, Luis Manuel Sánchez Navarro, Eduardo Pérez-Campos Mayoral, Carlos Alberto Matias Cervantes, Margarito Martínez Cruz, Gabriel Mayoral Andrade, Malaquías López Cervantes, Gabriela Vázquez Martínez, Claudia López Sánchez, Socorro Pina Canseco, Ruth Martínez Cruz, Eduardo Pérez-Campos |
| 32 |
[GO] |
2021―Mar―21 |
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs |
Anita Gupta, G. S. Gupta |
| 33 |
[GO] |
2021―Mar―19 |
Possible role of purinergic signaling in COVID-19 |
Maria Luiza Mukai Franciosi, Millena Daher Medeiros Lima, Maria Rosa Chitolina Schetinger, Andréia Machado Cardoso |
| 34 |
[GO] |
2021―Mar―19 |
The most important biomarker associated with coagulation and inflammation among COVID-19 patients |
Ling-Zhi Hong, Zhang-Xuan Shou, De-Ming Zheng, Xue Jin |
| 35 |
[GO] |
2021―Feb―19 |
Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives |
Tanusree Sengupta, Rinku Majumder, Samarpan Majumder |
| 36 |
[GO] |
2021―Feb―18 |
Therapeutic opportunities of edible antiviral plants for COVID-19 |
Bhoomika Patel, Supriya Sharma, Nisha Nair, Jaseela Majeed, Ramesh K. Goyal, Mahaveer Dhobi |
| 37 |
[GO] |
2021―Feb―10 |
Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
Mohammed Tarique, Shaban Ahmad, Arshi Malik, Irfan Ahmad, Mohd Saeed, Ahmad Almatroudi, Talal Qadah, Manal Abdulaziz Murad, Mutaib Mashraqi, Qamre Alam, Yousef Al-Saleh |
| 38 |
[GO] |
2021―Jan―22 |
Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage |
Suresh C. Tyagi, Mahavir Singh |
| 39 |
[GO] |
2021―Jan―03 |
COVID-19: advance in laboratory diagnostic strategy and technology |
Kezhen Yi, Yuan Rong, Cheng Wang, Lanxiang Huang, Fubing Wang |
| 40 |
[GO] |
2020―Nov―16 |
Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization |
Relja Suručić, Biljana Tubić, Miloš P. Stojiljković, Dragan M. Djuric, Maja Travar, Milkica Grabež, Katarina Šavikin, Ranko Škrbić |
| 41 |
[GO] |
2020―Oct―16 |
SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions |
Purva Asrani, Md. Imtaiyaz Hassan |
| 42 |
[GO] |
2020―Oct―07 |
Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19 |
Pravindra Kumar, Ashok Kumar Sah, Greesham Tripathi, Anjali Kashyap, Avantika Tripathi, Rashmi Rao, Prabhu C. Mishra, Koustav Mallick, Amjad Husain, Manoj Kumar Kashyap |
